The Kairos Synestherion Mk.II is the second and final iteration produced by Workshop Null, a three-person artisan collective operating from an undisclosed fabrication space within GLMZ's industrial mid-ring. Produced in a run of exactly 22 units — the collective has publicly stated no further production is planned — the Synestherion is a radical synesthetic BCI that permanently and deliberately reconfigures the cross-modal mapping of the wearer's sensory cortex. Rather than simulating synesthesia as an overlay, the Kairos rewires the underlying architecture: sound genuinely activates visual processing, emotional states manifest as tactile sensation across the skin, mathematical relationships produce olfactory signatures, and social dynamics are perceived as harmonic chord structures. The implant uses a hybrid of photonic signal routing and biochemical neuromodulator micro-infusion to achieve stable, persistent cross-modal binding, with a real-time adaptive algorithm that continuously refines the synesthetic mappings based on the user's neurological feedback over the first 90 days post-installation — a process Workshop Null calls 'blooming.'

Within artistic communities across GLMZ, the Synestherion has achieved something approaching mythological status. The 22 known Kairos users — who call themselves, without apparent irony, the 'Bloom' — produce work that defies conventional categorization: compositions that are simultaneously music and architecture, paintings that are also mathematical proofs experienced as scent-landscapes. Three Bloom members have held solo exhibitions at the Meridian Cultural Nexus; one, the sculptor-composer known only as Vessel, was offered TESSERA's artist residency stipend and publicly declined. Critics argue the Kairos represents the most significant development in human aesthetic perception since the invention of the electromagnetic spectrum display. Others argue that permanently altering one's neurology for art is a form of self-destruction Workshop Null is ethically obligated to prevent. Workshop Null has not responded.